_________________
September 23, 2024 | Rottendorf Pharma chose ValGenesis VLMS because of its capability to streamline and standardize processes coupled with the intuitive user interface of VLMS 5.0.
ValGenesis News
Rottendorf Pharma chose ValGenesis VLMS because of its capability to streamline and standardize processes coupled with the intuitive user interface of VLMS 5.0.
David joins ValGenesis with an impressive track record of driving marketing success across the enterprise SaaS, life sciences, and technology sectors.
ValGenesis and FrontWell Solutions collaborate to empower life sciences organizations, driving excellence in manufacturing and validation.
ValGenesis and Pharmasys are collaborating to enhance compliance processes in the European life sciences industry.
The company uses advanced nitrogen purging capabilities and is a state-of-the-art fill/finish CDMO specializing in sterile filling of vials, syringes, and cartridges for the biotech and pharmaceutical industries.
Validator’s services solve a range of key issues within the pharmaceutical industry, making them a go-to partner in Japanese life sciences.
The ValConnect conference, in Lisbon was a great success, with an excellent line-up of new releases and customer success stories for partners, customers, and industry experts.
ValGenesis and Zamann have partnered to provide customers in life sciences and other highly regulated industries across Europe.
Célere partners with life sciences and healthcare institutions to help them improve operational performance and regulatory compliance through digitized cGMP facilities, cGxP CSV.
ValGenesis Inc. announced the launch of VLMS 5.0, the new version of its flagship digital validation lifecycle management software poised to transform the industry's approach to digital transformation.